TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
Top Cited Papers
Open Access
- 3 August 2007
- journal article
- review article
- Published by Springer Nature in Virchows Archiv
- Vol. 451 (4) , 757-762
- https://doi.org/10.1007/s00428-007-0452-1
Abstract
Criteria for the staging and grading of neuroendocrine tumors (NETs) of midgut and hindgut origin were established at the second Consensus Conference in Frascati (Rome) organized by the European Neuroendocrine Tumor Society (ENETS). The proposed tumor–node–metastasis (TNM) classifications are based on the recently published ENETS Guidelines for the Diagnosis and Treatment of gastroenteropancreatic NETs and follow our previous proposal for foregut tumors. The new TNM classifications for NETs of the ileum, appendix, colon, and rectum, and the grading system were designed, discussed, and consensually approved by all conference participants. These proposals need to be validated and are meant to help clinicians in the stratification, treatment and follow-up of patients.Keywords
This publication has 37 references indexed in Scilit:
- Carcinoid of the Rectum Risk Stratification (CaRRS): A Strategy for Preoperative Outcome AssessmentAnnals of Surgical Oncology, 2006
- Endocrine Tumors of the Ileum: Factors Correlated with SurvivalNeuroendocrinology, 2006
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: Why Such Guidelines and How We Went about ItNeuroendocrinology, 2006
- Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?Annals of Oncology, 2005
- Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms) Part II—Specific NE Tumour TypesActa Oncologica, 2004
- Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms)Acta Oncologica, 2004
- From ENET to ENETS: A Long Odyssey in the Land of Small and Rare TumorsNeuroendocrinology, 2004
- Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of LanreotideNeuroendocrinology, 2004
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003